A synergistic blockade of OX40 and PD-1 potently enhances CD8+ T cell functionality, marked by increased secretion of Granzyme B and IFN-γ while concurrently depleting Tregs in the tumor, thereby inducing significant immunomodulation (114). The gene discussed is TNFRSF4; the disease is neoplasm.